1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base and Forecast Years Timeline
1.8. Key Benefits to the Stakeholder
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Research Processes
3. EXECUTIVE SUMMARY
3.1. Key Findings
3.2. CXO Perspective
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
4.5. Analyst View
5. ARTIFICIAL INTELLIGENCE (AI) IN PRECISION THERAPIES MARKET BY THERAPY TYPE
5.1. Introduction
5.2. Personalized Medicine
5.3. Targeted Therapies
5.4. Gene Therapies
5.5. Cell Therapies
5.6. Immunotherapies
5.7. Others
6. ARTIFICIAL INTELLIGENCE (AI) IN PRECISION THERAPIES MARKET BY APPLICATION
6.1. Introduction
6.2. Oncology
6.3. Neurology
6.4. Cardiology
6.5. Infectious Diseases
6.6. Rare Diseases
6.7. Autoimmune Diseases
6.8. Others
7. ARTIFICIAL INTELLIGENCE (AI) IN PRECISION THERAPIES MARKET BY END-USER INDUSTRY
7.1. Introduction
7.2. Hospitals And Clinics
7.3. Pharmaceutical And Biotechnology Companies
7.4. Research Institutes And Academic Centers
7.5. Others
8. ARTIFICIAL INTELLIGENCE (AI) IN PRECISION THERAPIES MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. By Therapy Type
8.2.2. By Application
8.2.3. BY End-User Industry
8.2.4. By Country
8.2.4.1. United States
8.2.4.2. Canada
8.2.4.3. Mexico
8.3. South America
8.3.1. By Therapy Type
8.3.2. By Application
8.3.3. BY End-User Industry
8.3.4. By Country
8.3.4.1. Brazil
8.3.4.2. Argentina
8.3.4.3. Others
8.4. Europe
8.4.1. By Therapy Type
8.4.2. By Application
8.4.3. BY End-User Industry
8.4.4. By Country
8.4.4.1. United Kingdom
8.4.4.2. Germany
8.4.4.3. France
8.4.4.4. Italy
8.4.4.5. Spain
8.4.4.6. Others
8.5. Middle East and Africa
8.5.1. By Therapy Type
8.5.2. By Application
8.5.3. BY End-User Industry
8.5.4. By Country
8.5.4.1. Saudi Arabia
8.5.4.2. UAE
8.5.4.3. Others
8.6. Asia Pacific
8.6.1. By Therapy Type
8.6.2. By Application
8.6.3. BY End-User Industry
8.6.4. By Country
8.6.4.1. Japan
8.6.4.2. China
8.6.4.3. India
8.6.4.4. South Korea
8.6.4.5. Taiwan
8.6.4.6. Thailand
8.6.4.7. Indonesia
8.6.4.8. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. IBM Watson Health (IBM Corporation)
10.2. Google Health (Alphabet Inc.)
10.3. Tempus Labs, Inc.
10.4. Nvidia Corporation
10.5. Deep Genomics, Inc.
10.6. Microsoft Corporation
10.7. Owkin, Inc.
10.8. Benevolentai Ltd.
10.9. Recursion Pharmaceuticals, Inc.
10.10. Cloud Pharmaceuticals, Inc.